Penn Medicine
Help | Search | Site Map | Contact   
faculty photo

Edmund K Moon, MD

Assistant Professor of Medicine at the Hospital of the University of Pennsylvania
Department: Medicine

Contact information
University of Pennsylvania/Pulmonary
Stemmler Hall, 2nd Floor, Lab 261
3450 Hamilton Walk
Philadelphia, PA 19104
Office: (215) 908-1454
Lab: (215) 746-8008
Graduate Group Affiliations
B.A. (Biology & Psychology)
The Johns Hopkins University, 2000.
University of Maryland School of Medicine , 2004.
Post-Graduate Training
Internal Medicine Residency, Temple University, 2004-2007.
Pulmonary, Allergy, & Critical Care Fellowship, University of Pennsylvania, 2007-2011.
Interventional Pulmonary Fellowship, University of Pennsylvania, 2011-2012.
American Board of Internal Medicine, 2007.
American Board of Pulmonary Disease, 2009.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Kheng Newick, Shaun O'Brien, Edmund Moon, Steven M. Albelda: CAR T Cell Therapy for Solid Tumors. Annual Review of Medicine February 2017.

Matthew Riese, Edmund Moon, Bryon Johnson, Steven Albelda: Diacylglycerol kinases (DGKs): novel targets for improving T cell activity in cancer. Signaling October 2016.

Singhal S, Bhojnagarwala PS, O'Brien S, Moon EK, Garfall AL, Rao AS, Quatromoni JG, Stephen TL, Litzky L, Deshpande C, Feldman MD, Hancock WW, Conejo-Garcia JR, Albelda SM, Eruslanov EB.: Origin and Role of a Subset of Tumor-Associated Neutrophils with Antigen-Presenting Cell Features in Early-Stage Human Lung Cancer. Cancer Cell 30, July 2016.

Xiaojun Liu, Raghuveer Ranganathan, Shuguang Jiang, Chongyun Fang, Jing Sun, Soyeon Kim, Kheng Newick, Albert Lo, Carl H. June, Yangbing Zhao, Edmund K. Moon: A chimeric switch-receptor targeting PD1 augments the efficacy of second generation CAR T-cells in advanced solid tumors. Cancer Research 76(6): 1578-1590, Mar 2016.

Edmund K Moon,Raghuveer Ranganathan, Evgeniy Eruslanov, Soyeon Kim, Kheng Newick, Shaun O'Brien, Albert Lo, Xiaojun Liu, Yangbing Zhao, and Steven M. Albelda : Blockade of Programmed Death 1 Augments the Ability of Human T cells Engineered to Target NY-ESO-1 to Control Tumor Growth after Adoptive Transfer Clinical Cancer Research 22(2): 436-7, Jan 2016.

Newick K, Moon E, Albelda SM: Chimeric antigen receptor T-cell therapy for solid tumors. Molecular Therapy - Oncolytics 3: 16006, 2016.

Kennedy Gregory T, Judy Brendan F, Bhojnagarwala Pratik, Moon Edmund K, Fridlender Zvi G, Albelda Steven M, Singhal Sunil: Surgical cytoreduction restores the antitumor efficacy of a Listeria monocytogenes vaccine in malignant pleural mesothelioma. Immunology letters 166(1): 28-35, May 2015.

Moon EK, Litzky LA, Sterman DH: Malignant mesothelioma and other primary pleural tumors. Fishman’s Pulmonary Diseases and Disorders. 5th ed. Grippi M, Fishman, J, Kotloff R, Pack A, Senior R. (eds.). McGraw-Hill, Page: 1216-1225, 2015.

Kheng Newick, Shaun O'Brien, Veena Kapoor, Liang-chuan Wang, Edmund Moon, Daniel Sterman, Steven Albelda: Histamine dihydrochloride as an immune modulator for solid tumors. AACR 2015 (Philadelphia, PA) 2015.

Enxiu Wang , Dr. Liang-Chuan S. Wang , Ching-Yi Tsai , Vijay Bhoj , Zachary Gershenson , Dr. Edmund K. Moon , Dr. Kheng Newick , Dr. Jing Sun , Mr. Albert Lo , Timothy Baradet , Dr. Michael Feldman , Dr. David M. Barrett , Dr. Ellen Pure , Dr. Steven M. Albelda : Generation of Potent T cell Immunotherapy for Cancer using Killer Immunoglobulin-like Receptor-based Chimeric Immunoreceptors Cancer Immunology Research 3(1): 815-26, 2015.

back to top
Last updated: 03/31/2017
The Trustees of the University of Pennsylvania
© The Trustees of the University of Pennsylvania. Site best viewed with Mozilla, NN, IE, or Safari.
SOM Home International Programs Penn Alumni Clinical Trials Centers and Institutes Departments Faculty Research Education Administration